NCT05834075View on ClinicalTrials.gov

A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Neurovascular Age-related Macular Degeneration
Trial Locations (4)

Unknown

Narayana Nethralaya, Bangalore

Disha Eye Hospital, Kolkata

Susrut Eye Foundation and Research Center, Kolkata

Dr. Milan's Retina Care Center, Rajkot

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY